Heart failure & cardiomyopathies

Clinical Profiles and Prognostic Impact of Residual Intravascular and Tissue Congestion in Acute Heart Failure

Eur J Heart FailPublished Secondary analysis of the PROTECT and RELAX-AHF-2 randomised trials

Authors' conclusion

Patients with intravascular RC had better diuretic responses and shorter hospital stays than those with tissue/combined RC, but worse outcomes than decongested patients.

Study context

Population
Patients with acute decompensated heart failure (ADHF) and congestion at admission (PROTECT and RELAX-AHF-2 trials)580 (37%) with residual congestion
Participants
1,557 patients
Comparison
Residual congestion phenotypes at day 7/discharge vs decongested
  • Intravascularn = 260
  • Combinedn = 185
  • Tissuen = 135
Primary endpoint
All-cause mortality
Follow-up
180 days
Methodological detailsindex and replication cohorts
  • Index and replication cohorts

Primary result

As reported in the abstract

180-day mortality
Adjusted
Each group vs decongestedHazard ratio (95% CI)
Intravascular
1.69(1.15–2.49)
Tissue
2.07(1.25–3.41)

Further findings

In-hospital diuretic response, length of stay, IV loop diuretic dose · during hospitalization

Solely intravascular residual congestion (RC): greater diuretic responses, shorter stays and lower IV loop diuretic doses vs tissue or combined
all p < 0.05

180-day mortality, RELAX-AHF-2 substudy (replication)

Similar findings observed
  • n = 476

Original publication

Clinical Profiles and Prognostic Impact of Residual Intravascular and Tissue Congestion in Acute Heart Failure. Eur J Heart Fail. Published 11 November 2025. doi:10.1002/ejhf.70091

Summarised from the published abstract; every number is checked against it

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.